Influence
September 28, 2020

Containing COVID on campus: Regenstrief VP serves as IU director of mitigation

Reopening college campuses has been particularly challenging during the COVID-19 pandemic. Regenstrief Vice President for Faculty Development Aaron Carroll, M.D., has guided Indiana University’s return, serving as the director of surveillance and mitigation for COVID-19.  

IU’s multi-tiered testing program is the cornerstone of the university’s plan to allow in-person instruction and on-campus living while minimizing the spread of the virus. Faculty, staff, and on-campus students were tested when they arrived to campus, and ongoing testing continues to monitor the spread. Dr. Carroll helped develop the program.  

The mitigation testing will quickly identify emerging clusters of cases and allow people who test positive to isolate before they have a chance to infect others. The testing will cover thousands of people every week across all nine IU campuses. Dr. Carroll believes this level of screening is the best tool to keep an outbreak at bay.  

Dr. Carroll has been a strong proponent of robust testing to mitigate the spread of the virus since early in the pandemic. He has written several opinion pieces in the New York Times and appeared on many national news networks to discuss the importance of testing.  

In addition to being the vice president of faculty development at Regenstrief Institute, Dr. Carroll is also a professor of pediatrics, vice chair of health outcomes research faculty development and the associate dean of research mentoring at Indiana University School of Medicine. 

Related News

doctor using electronic health record

Data expertise helps researchers understand how clinical tools are used in real-world care

Regenstrief Data Services (RDS) provided critical health data and specialized expertise to support research examining clinical decision-support use across

Regenstrief Institute and Suki partner to evaluate ambient AI in healthcare

Organizations share a commitment to understanding how ambient AI technologies impact clinicians, patients and healthcare delivery  Regenstrief Institute and Suki, a

Dr. Peter J. Embi

Regenstrief’s legacy with the National Library of Medicine continues

Peter J. Embí, M.D., M.S., former president and CEO of the Regenstrief Institute, has been appointed director of the

image showing two people connecting through a kidney

Regenstrief Institute awarded KidneyX prize to advance living kidney donation

LIVINGkidney digital tool recognized in national HHS competition focused on reducing barriers for living kidney donors and transplant patients  Regenstrief